Source: International Congress 2019 – Long-term lung function: from early birth to adulthood
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Håkansson (Copenhagen, Denmark), L. J. H. Rasmussen (Copenhagen, Denmark), N. S. Godtfredsen (Copenhagen, Denmark), O. Djurhuus Tupper (Copenhagen, Denmark), J. Eugen-Olsen (Copenhagen, Denmark), T. Kallemose (Copenhagen, Denmark), O. Andersen (Copenhagen, Denmark), K. Marsaa (Copenhagen, Denmark), C. S. Ulrik (Copenhagen, Denmark). Soluble urokinase plasminogen activator receptor (suPAR) predicts hospital readmissions and all-cause mortality in patients admitted with asthma. 1941

Member's Comments

No comment yet.

Related content which might interest you: Soluble urokinase plasminogen activator receptor (suPAR) is associated with COPD readmission and mortality Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019 Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP) Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia Source: ERJ Open Res, 5 (1) 00212-2018; 10.1183/23120541.00212-2018 Year: 2019 Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 The relation between plasminogen activator inhibitor-1 (PAI-1) and inflammatory markers in COPD: A possible risk factor of inflammation-induced thrombosis Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Soluble urokinase-type plasminogen activator receptor in monitoring of treatment response in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Prognostic value of urokinase plasminogen activator receptor (uPAR) and neutrophil CD64 expression in acute respiratory distress syndrome patients Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Half - dose of recombinant tissue-type plasminogen activator in the treatment of acute pulmonary embolism: long term outcomes Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Upregulation of the gene encoding the urokinase-type plasminogen activator (uPA) in respiratory muscles of COPD patients Source: Annual Congress 2004 - Skeletal muscle in respiratory disease Year: 2004 C-reactive protein as a predictor of mortality in patients with severe sepsis in intensive care unit Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances Year: 2011 Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017 30-days mortality in patients admitted with COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma Source: Eur Respir J 2016; 47:1568-1571 Year: 2016 Clinical pathway for acute COPD exacerbations reduces hospital stay and readmission rate Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Clinical pathway for acute COPD exacerbations reduces hospital stay and readmission rate Source: Annual Congress 2008 - Impact of nursing interventions on the quality of care for COPD patients Year: 2008 Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017